5

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: January 18, 2013
Period of Report: December 31, 2012
Accession Number: 0001514955-13-000001

View Document ↗ View on SEC.gov ↗